Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy.

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology (2009) 1.26

Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol (2008) 1.21

Social support and Quality of Life: a cross-sectional study on survivors eight months after the 2008 Wenchuan earthquake. BMC Public Health (2010) 1.20

Classification of cirrhotic patients with or without minimal hepatic encephalopathy and healthy subjects using resting-state attention-related network analysis. PLoS One (2014) 0.88

Health-related quality of life in chinese patients with chronic liver disease. Gastroenterol Res Pract (2012) 0.86

Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci (2016) 0.80

Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom. Health Qual Life Outcomes (2014) 0.79

Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort. Hepat Res Treat (2013) 0.76

Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment. Patient Prefer Adherence (2017) 0.75

Can Testing the Impact of Minimal Hepatic Encephalopathy on Driving Skills be Prolific to Translate Research to Real Life Clinical Medicine? J Clin Exp Hepatol (2016) 0.75

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02

Measuring health-related quality of life. Ann Intern Med (1993) 11.84

Assesment of quality-of-life outcomes. N Engl J Med (1996) 8.66

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology (2002) 7.53

Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol (2003) 5.16

Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol (1998) 4.94

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology (2007) 4.35

Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.47

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut (1999) 2.98

Subclinical hepatic encephalopathy impairs daily functioning. Hepatology (1998) 2.23

Minimal hepatic encephalopathy impairs fitness to drive. Hepatology (2004) 2.20

Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology (1978) 1.97

Screening of subclinical hepatic encephalopathy. J Hepatol (2000) 1.96

Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol (2001) 1.89

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol (2001) 1.84

Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl (2006) 1.77

Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69

The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol (2000) 1.44

Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol (2001) 1.17

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol (1986) 1.16

Validation of the German version of the Chronic Liver Disease Questionnaire. Eur J Gastroenterol Hepatol (2004) 1.14

Quality-of-life assessments and chronic liver disease. Am J Gastroenterol (1998) 1.12

Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis (2001) 1.10

Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol (1996) 1.06

Subclinical hepatic encephalopathy. Semin Liver Dis (1996) 1.00

Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol (2004) 0.93

Subclinical portal-systemic encephalopathy. Am J Gastroenterol (1988) 0.84

Methods in outcomes research in hepatology: definitions and domains of quality of life. Hepatology (1999) 0.83

[Measuring quality of life in gastroenterology--concepts, instruments and problems]. Z Gastroenterol (2001) 0.82

Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology (1998) 0.82

Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol (2010) 1.63

Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol (2003) 1.47

Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol (2010) 1.45

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology (2005) 1.42

Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One (2011) 1.27

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World J Gastroenterol (2003) 1.19

IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology (2014) 1.15

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial. World J Gastroenterol (2003) 1.04

Anti-proliferative effect of Juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-dependent pathway. Eur J Pharmacol (2010) 1.04

Effect of lipid on proliferation and activation of rat hepatic stellate cells (I). World J Gastroenterol (1998) 1.03

Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol (2003) 1.02

Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. J Lipid Res (2010) 0.99

Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J Gastroenterol (2002) 0.99

The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun (2012) 0.98

Th17 cells: the emerging reciprocal partner of regulatory T cells in the liver. J Dig Dis (2010) 0.97

Study on the role of free fatty acids in proliferation of rat hepatic stellate cells (II). World J Gastroenterol (1998) 0.96

Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol (2006) 0.96

Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies. World J Gastroenterol (2011) 0.93

Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines. World J Gastroenterol (2004) 0.92

Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun (2012) 0.92

Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol Res (2013) 0.91

Relationship between clinical and pathologic findings in patients with chronic liver diseases. World J Gastroenterol (2003) 0.91

Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. J Dig Dis (2009) 0.88

Proteome of human colon cancer stem cells: a comparative analysis. World J Gastroenterol (2011) 0.88

Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients. J Gastroenterol Hepatol (2003) 0.87

Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells. FEBS Lett (2013) 0.86

CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J Lipid Res (2012) 0.86

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J Gastroenterol (2004) 0.85

Ginsenoside Rb3 inhibits angiotensin II-induced vascular smooth muscle cells proliferation. Basic Clin Pharmacol Toxicol (2010) 0.85

20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway. Am J Chin Med (2013) 0.84

Liver fibrogenesis in non-alcoholic steatohepatitis. Front Physiol (2012) 0.83

Expression of p21(WAF1) is related to acetylation of histone H3 in total chromatin in human colorectal cancer. World J Gastroenterol (2007) 0.83

The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity. PLoS One (2011) 0.83

Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease. Dig Dis Sci (2011) 0.83

Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy. J Dig Dis (2012) 0.83

Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population. Clin Rev Allergy Immunol (2015) 0.82

Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience. J Dig Dis (2013) 0.82

Liver X receptors bridge hepatic lipid metabolism and inflammation. J Dig Dis (2012) 0.81

[Effects of CASI on myocardial ischemia-reperfusion arrhythmia in rats]. Zhongguo Zhong Yao Za Zhi (2007) 0.80

Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol (2015) 0.80

A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int (2004) 0.80

Hyperlipidemic versus healthy pancreases: a proteomic analysis using an animal model. IUBMB Life (2010) 0.80

Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice. World J Gastroenterol (2004) 0.80

Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysis. World J Gastroenterol (2009) 0.80

Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol (2013) 0.79

Expression of huCdc7 in colorectal cancer. World J Gastroenterol (2013) 0.79

Determination of tetracyclines residues in honey using high-performance liquid chromatography with potassium permanganate-sodium sulfite-beta-cyclodextrin chemiluminescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.79

[Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis]. Zhonghua Gan Zang Bing Za Zhi (2011) 0.79

20(S)-Protopanaxadiol induces human breast cancer MCF-7 apoptosis through a caspase-mediated pathway. Asian Pac J Cancer Prev (2014) 0.79

[Relationship between type I autoimmune hepatitis and alleles of HLA-DRB1 in Chinese patients of Shanghai area]. Zhonghua Gan Zang Bing Za Zhi (2002) 0.79

[Genetic analysis of segregation distortion of molecular markers in maize F2 population]. Yi Chuan Xue Bao (2003) 0.78

The role of liver stiffness measurement in the evaluation of liver function and esophageal varices in cirrhotic patients. J Dig Dis (2015) 0.78

[Methods for diagnosis of minimal hepatic encephalopathy and their evaluation]. Zhonghua Gan Zang Bing Za Zhi (2005) 0.77

Three case reports of inherited antithrombin deficiency in China: double novel missense mutations, a nonsense mutation and a frameshift mutation. J Thromb Thrombolysis (2012) 0.77

[Effects of continuous early enteral nutrition on the gut barrier function in dogs with acute necrotizing pancreatitis]. Zhonghua Yi Xue Za Zhi (2004) 0.77

Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B. World J Gastroenterol (2007) 0.76

[Comparative analyses of QTL for important agronomic traits between maize and rice]. Yi Chuan Xue Bao (2004) 0.76

2-Chloro-4-(3,3-dichloro-all-yloxy)-1-nitro-benzene. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75

[Assessment of the health-related quality of life of patients with minimal hepatic encephalopathy]. Zhonghua Gan Zang Bing Za Zhi (2007) 0.75

Hypolipidemic effects of kaempferide-7-O-(4''-O-acetylrhamnosyl)-3-O-rutinoside in hyperlipidemic rats induced by a high-fat diet. Mol Med Rep (2011) 0.75

[Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome]. Zhonghua Gan Zang Bing Za Zhi (2008) 0.75

[Diagnosis and management of autoimmune hepatitis with acute presentation]. Zhonghua Gan Zang Bing Za Zhi (2012) 0.75

[Clinical and pathological features of autoimmune hepatitis: no significant differences between genders]. Zhonghua Gan Zang Bing Za Zhi (2012) 0.75

[The diagnosis and management of autoimmune liver diseases]. Zhonghua Gan Zang Bing Za Zhi (2005) 0.75

[Metabolic nuclear receptors and primary biliary cirrhosis]. Zhonghua Gan Zang Bing Za Zhi (2011) 0.75

[Traditional Tibetan medicine plant resource of Polygonaceae family in eastern of Qinghai-Tibet plateau]. Zhongguo Zhong Yao Za Zhi (2009) 0.75

A Novel Mutation of ABCB4 in Progressive Familial Intrahepatic Cholestasis 3: Like Mother, Like Daughter. J Clin Gastroenterol (2016) 0.75

[Effect of enalapril on caspase 3 in experimental liver fibrotic rats]. Zhonghua Gan Zang Bing Za Zhi (2005) 0.75

[Differential diagnosis and therapy for autoimmune hepatitis and drug-induced liver injury]. Zhonghua Gan Zang Bing Za Zhi (2012) 0.75

[Clinical and medication characteristics of senior hospitalized patients with chronic constipation]. Zhonghua Yi Xue Za Zhi (2012) 0.75

[QTL mapping of five agronomic traits in maize]. Yi Chuan Xue Bao (2005) 0.75

Aetiological spectrum and antibiotic susceptibility pattern of bacterial meningitis in infants and children in Hangzhou, China. Acta Paediatr (2005) 0.75

[A meibomian gland massage mechanism for upper and lower eyelids based on anti-phase rolling and enveloping movement]. Zhongguo Yi Liao Qi Xie Za Zhi (2014) 0.75

Flow injection analysis of tetracyclines using inhibited Ru(bpy)3(2+)/tripropylamine electrochemiluminescence system. Luminescence (2005) 0.75

[Clinical and pathological features of primary biliary cirrhotic patients with negative anti-mitochondria antibody]. Zhonghua Gan Zang Bing Za Zhi (2011) 0.75

[Diagnosis and treatment of cholestatic liver disease]. Zhonghua Gan Zang Bing Za Zhi (2015) 0.75

Flow-injection determination of streptomycin residues in milk using the luminol-periodate-Mn2+ chemiluminescence system. Luminescence (2006) 0.75

Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study. Hepatobiliary Pancreat Dis Int (2004) 0.75